Iga Swiatek accepts one month suspension by ITIA after testing positive for TMZ | Tennis News
The International Tennis Integrity Agency (ITIA) said on Thursday that world number two Iga Swiatek has accepted a one-month suspension after testing positive for banned substance trimetazidine (TMZ). The Polish player had tested positive in an out-of-competition sample back in August but the agency noted that it was caused by contamination of her medication melatonin which she has been taking for sleep issues and jet lag. Due to there being no significant fault or negligence on part of the player, the ITIA offered her a one-month suspension which she accepted. Statement from the WTA: The WTA acknowledges the decision by the International Tennis Integrity Association (ITIA) – which administers the Tennis Anti-Doping Program (TADP) – in issuing a one-month suspension to Iga Swiatek, following the identification of a contaminated… — wta (@WTA) November 28, 2024 “The player was provisionally suspended from Sept. 22 until Oct. 4, missing three tournaments, which counts towards the sanction, leaving eight days remaining. In addition, the player also forfeits prize money from the Cincinnati Open, the tournament directly following the …

